Biotech - Press Releases

Date	Title	Company
26-Jan-2023	Bloomsbury Genetic Therapies Announces Orphan Drug Designations of BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome	Bloomsbury Genetic Therapies Limited
26-Jan-2023	Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize	University of Calgary
26-Jan-2023	Nutricia pioneers its first plant-based medical nutrition drink	Nutricia
26-Jan-2023	Cancer cells shrink or super-size to survive	The Institute of Cancer Research
26-Jan-2023	bit.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells	Automata
25-Jan-2023	Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor	Rewind Therapeutics
24-Jan-2023	Aston University collaborates with biotechnology start-up to develop drugs to tackle lung disease	Aston University
24-Jan-2023	Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022	Genmab
20-Jan-2023	Benchling appoints first EMEA general manager amidst rapid European growth	Benchling
20-Jan-2023	Isorg collaborates with Precise Biometrics on turnkey fingerprint sensor solution for smartphone industry	Andrew Lloyd Associates
19-Jan-2023	NETRIS Pharma led consortium awarded €1.2 million Eurostar grant to explore netrin-1 targeted therapeutics	Netris Pharma
19-Jan-2023	SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab	SOTIO Biotech
19-Jan-2023	Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium	Servier and Taiho Oncology
19-Jan-2023	DeuterOncology closes €5.65M Series A financing round	Andrew Lloyd Associates
17-Jan-2023	Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors	Tune Therapeutics
17-Jan-2023	Ovarian cancer: Innovative research approach identifies target proteins for potential anti-tumor drug rhenium tricarbonyl (TRIP).	IMC Krems – University of Applied Sciences
17-Jan-2023	SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial	SolasCure
17-Jan-2023	Enalees appoints Eric Germain as managing director	Andrew Lloyd Associates
17-Jan-2023	Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next-Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality	Avectas
17-Jan-2023	ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002	ImmunOs Therapeutics